Terran Biosciences (“Terran”), a biotechnology platform company focused on the development of transformational drugs for neurological and psychiatric diseases, has entered into an agreement with Concert Pharmaceuticals (“Concert”) to acquire Concert’s portfolio of CNS therapeutics, including related intellectual property. Read More
Trending News
Scenic Biotech Announces $31 Million Financing to Progress Pipeline of Genetic Modifiers in Cancer and Rare Diseases
Investment will accelerate Scenic Biotech’s transition into a development stage company, advancing its in-house pipeline and supporting the creation of new programs based on its Cell-Seq genetic modifier target discovery platform including new industry collaborations. Read More
MedCrypt Wins Cybersecurity Contracts From Three Major Surgical Robotics Companies to Help Drive Secure Innovation
MedCrypt, Inc., the proactive cybersecurity solution provider for medical devices and manufacturers, today announced it is supporting three companies building surgical robotics systems to secure various aspects of their systems and interoperable system suites. Customers include the leading manufacturers of surgical robotics technologies and virtual reality applications for minimally invasive […]
Ankura Launches Pharmaceutical Data Integrity Solution
Ankura Consulting, LLC (“Ankura”), a leading global expert services and advisory firm, today announced the expansion of its Pharmaceutical and Biopharma Regulatory Compliance offering with the addition of a Pharmaceutical Data Integrity solution within the Data and Technology practice, bolstering its comprehensive client advisory capabilities. Read More
WuXi ATU Announces Launch of TESSA™ Technology to Improve Scalability and Accessibility of Cell and Gene Therapies
WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, today announced the launch of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA™). This technology is a state-of-the-art novel process for transfection-free, scalable manufacture of adeno-associated virus (AAV) at Good Manufacturing Practice (GMP) grade. Developed by OXGENE in the United Kingdom, a […]
BayCare Expands Partnership with Feeding Tampa Bay, Opens Health Education Center
ucked inside the massive industrial warehouse home of Feeding Tampa Bay, guests, staff and volunteers now have their own dedicated BayCare Health Education Center. The first of its kind, the facility reflects BayCare’s commitment to addressing the community’s health holistically. The center will serve as a resource for visitors to […]
PIH Health Launches New In-Home Care Business Line with 24 Hour Home Care
A Los Angeles-based health system is teaming up with a home care provider to give patients an easier path in their pursuit of aging in place. PIH Health announced Thursday it is teaming up with 24 Hour Home Care and adding a customized service called “PIH Health at Home.” Read […]
Prescient Healthcare Group Acquires Strategic North
Prescient, a biopharma product and portfolio strategy firm, announces the recent acquisition of Strategic North, a global commercial strategy consultancy that partners with a wide range of pharmaceutical companies to help them better understand how their customers make decisions in order to unlock the full potential of their brands. Read […]
CPSI Announces the Acquisition of Healthcare Resource Group, Inc.
MOBILE, Ala.-CPSI, a healthcare solutions company, today announced that it has acquired Healthcare Resource Group, Inc. (“HRG”). Based in Spokane, Washington, HRG is a leading provider of customized revenue cycle management (“RCM”) solutions and consulting services that enable hospitals and clinics to improve efficiency, profitability, and patient satisfaction. Founded in […]
Biocon Biologics to acquire biosimilar assets from Viatris raising up to USD 3.335 billion in equity and cash
Biocon Biologics Ltd. , a subsidiary of Biocon Ltd. (BSE code: 532523) (NSE: BIOCON), has entered into a definitive agreement with its partner Viatris Inc. (NASDAQ) : VTRS ). Under the agreement, Biocon Biologics Ltd. (BBL) will acquire Viatris’ biosimilars business to create a fully integrated global biosimilars business. It […]
